Market research
300016.SHE Beijing Beilu Pharmaceutical Co., Ltd
SHE CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 6B
- P/E ratio
- 45.39
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.26
Community
Investor discussion
1 comment
Sign in to join the 300016.SHE discussion.
5 years, 4 months ago
Beijing Beilu Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 11.0% below its 200 day moving average.
From a valuation standpoint, the stock is 43.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.4.
Beijing Beilu Pharmaceutical Co., Ltd's total revenue sank by 3.6% to $204M since the same quarter in the previous year.
Its net income has dropped by 91.9% to $14M since the same quarter in the previous year.
Finally, its free cash flow fell by 96.0% to $1M since the same quarter in the previous year.
Based on the above factors, Beijing Beilu Pharmaceutical Co., Ltd gets an overall score of 1/5.